US Stock MarketDetailed Quotes

ANRO Alto Neuroscience

Watchlist
  • 3.360
  • +0.100+3.07%
Close Feb 14 16:00 ET
  • 3.360
  • 0.0000.00%
Post 17:51 ET
90.62MMarket Cap-1.58P/E (TTM)

About Alto Neuroscience Company

Alto Neuroscience, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of psychiatric drugs. Its pipeline is composed of five clinical-stage assets which initially target depressive disorder and schizophrenia population. The company was founded by Amit Etkin, Dan Segal, and Wei Wu on March 25, 2019 and is headquartered in Mountain View, CA.

Company Profile

SymbolANRO
Company NameAlto Neuroscience
Listing DateFeb 2, 2024
Issue Price16.00
Founded2019
CEODr. Amit Etkin, M.D.
MarketNYSE
Employees63
Fiscal Year Ends12-31
Address650 Castro Street,Suite 450
CityMountain View
ProvinceCalifornia
CountryUnited States of America
Zip Code94041
Phone1-650-200-0412
Websitehttp://www.altoneuroscience.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Amit Etkin, M.D.
  • President, Chief Executive Officer and Chairman of the Board
  • 1.86M
  • Adam Savitz
  • Chief Medical Officer
  • 1.24M
  • Nicholas Conrad Smith
  • Chief Financial Officer and Principal Accounting Officer
  • 1.60M
  • Michael Conick Hanley, Jr
  • Chief Operating Officer
  • --
  • Dr. Husseini Manji
  • Independent Director
  • --
  • Gwill York
  • Independent Director
  • 53.68K
  • Christopher Nixon Cox
  • Independent Director
  • --
  • Andrew Dreyfus
  • Independent Director
  • 107.37K
  • Mahalakshmi Radhakrishnan, M.D.
  • Independent Director
  • --
  • Dr. Po Yu Chen
  • Independent Director
  • --

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
HENDERA
831152
+30.00%
Hengerda New Materials
300946
+20.01%
Fujian Nebula Electronics.,Ltd
300648
+20.00%
4
Cubic Digital Technology
300344
+19.98%
5
HNAC Technology
300490
+19.95%
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.
Discussing
FOMC leaves rates unchanged, how will you adjust your portfolio?
FOMC left the target Federal Funds rate unchanged at at target of 4.25%-4.5%, how will you adjust your portfolio? Show More
FOMC Press Conference, January 29, 2025